Cytosorbents (CTSO) Finished Goods (2023 - 2026)

Cytosorbents (CTSO) has 4 years of Finished Goods data on file, last reported at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 45.72% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 45.72% YoY), and the FY2025 full-year result was $3.5 million, up 112.53% from the prior year.
• Finished Goods for Q1 2026 stood at $2.7 million, down from $3.5 million in the prior quarter.
• Across five years, Finished Goods topped out at $3.5 million in Q4 2025 and bottomed at $1.7 million in Q4 2024.
• The 4-year median for Finished Goods is $2.3 million (2025), against an average of $2.3 million.
• The widest annual swing landed in 2024, when Finished Goods declined 10.33%; it then soared 112.53% in 2025.
• A 4-year view of Finished Goods shows it stood at $1.9 million in 2023, then dropped by 10.33% to $1.7 million in 2024, then soared by 112.53% to $3.5 million in 2025, then decreased by 23.58% to $2.7 million in 2026.
• The last three Finished Goods figures came in at $2.7 million (Q1 2026), $3.5 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison